Search Results - "Pilger, Ernst"

Refine Results
  1. 1
  2. 2

    Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients by Gary, Thomas, Pichler, Martin, Belaj, Klara, Hafner, Franz, Gerger, Armin, Froehlich, Harald, Eller, Philipp, Rief, Peter, Hackl, Gerald, Pilger, Ernst, Brodmann, Marianne

    Published in PloS one (02-07-2013)
    “…Platelet-to-Lymphocyte Ratio (PLR) is an easily applicable blood test. An elevated PLR has been associated with poor prognosis in patients with different…”
    Get full text
    Journal Article
  3. 3

    Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients by Gary, Thomas, Pichler, Martin, Belaj, Klara, Hafner, Franz, Gerger, Armin, Froehlich, Harald, Eller, Philipp, Pilger, Ernst, Brodmann, Marianne

    Published in PloS one (15-02-2013)
    “…The Neutrophil-to-Lymphocyte ratio (NLR) is an easy to perform test from the white blood cell count. An increase in NLR has been associated with vascular…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Paclitaxel-Coated Balloon in Infrapopliteal Arteries by Zeller, Thomas, MD, Beschorner, Ulrich, MD, Pilger, Ernst, MD, Bosiers, Marc, MD, Deloose, Koen, MD, Peeters, Patrick, MD, Scheinert, Dierk, MD, PhD, Schulte, Karl-Ludwig, MD, PhD, Rastan, Aljoscha, MD, Brodmann, Marianne, MD, PhD

    Published in JACC. Cardiovascular interventions (01-10-2015)
    “…Abstract Objectives The aim of BIOLUX P-II (BIOTRONIK'S–First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Polymorphisms of the hypoxia-inducible factor 1 gene and peripheral artery disease by Bahadori, Babak, Uitz, Elisabeth, Mayer, Andreas, Harauer, Jürgen, Dam, Karl, Truschnig-Wilders, Martini, Pilger, Ernst, Renner, Wilfried

    Published in Vascular medicine (London, England) (01-10-2010)
    “…Hypoxia-inducible factor 1 (HIF1) is a key regulator of angiogenesis and is involved in inflammation, which are two important features of the pathogenesis of…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    The angiotensin-converting-enzyme insertion/deletion polymorphism is not related to venous thrombosis by Köppel, Herwig, Renner, Wilfried, Gugl, Alexander, Cichocki, Lisa, Gasser, Robert, Wascher, Thomas C, Pilger, Ernst

    Published in Thrombosis and haemostasis (01-01-2004)
    “…The insertion/deletion (I/D) polymorphism of the gene for angiotensin-converting-enzyme (ACE) is associated with ACE plasma levels and activity. Conflicting…”
    Get more information
    Journal Article
  11. 11

    Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients by Cohen, Alexander T, Harrington, Robert A, Goldhaber, Samuel Z, Hull, Russell D, Wiens, Brian L, Gold, Alex, Hernandez, Adrian F, Gibson, C. Michael

    Published in The New England journal of medicine (11-08-2016)
    “…In a subgroup of hospitalized patients with an elevated d -dimer level, there was no significant benefit for oral betrixaban over subcutaneous enoxaparin on…”
    Get full text
    Journal Article
  12. 12

    Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease by Renner, W, Köppel, H, Brodmann, M, Pabst, E, Schallmoser, K, Toplak, H, Wascher, T C, Pilger, E

    Published in Thrombosis and haemostasis (01-01-2000)
    “…G to A mutations at positions 20210 of the prothrombin gene (F2) and 1691 of the factor V gene (F5) are established risk factors for venous thrombosis. Several…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Simultaneous in vivo quantitation of vascular endothelial growth factor mRNA splice variants by Renner, W, Pilger, E

    Published in Journal of vascular research (01-03-1999)
    “…Vascular endothelial growth factor (VEGF) is an important regulator of angiogenesis. In vivo expression of four different VEGF isoforms, consisting of 121,…”
    Get more information
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    AMS INSIGHT—Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis by Bosiers, Marc

    “…Endoluminal treatment of infrapopliteal artery lesions is a matter of controversy. Bioabsorbable stents are discussed as a means to combine mechanical…”
    Get full text
    Journal Article